| Drug treatments for covid-19: living systematic review and network meta-analysis RAC Siemieniuk, JJ Bartoszko, L Ge, D Zeraatkar, A Izcovich, E Kum, ... Bmj 370, 2020 | 943 | 2020 |
| Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory … Z Ye, Y Wang, LE Colunga-Lozano, M Prasad, W Tangamornsuksan, ... Cmaj 192 (27), E756-E767, 2020 | 273 | 2020 |
| Prophylaxis against covid-19: living systematic review and network meta-analysis JJ Bartoszko, RAC Siemieniuk, E Kum, A Qasim, D Zeraatkar, L Ge, ... bmj 373, 2021 | 112 | 2021 |
| Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline Z Ye, AR Blaser, L Lytvyn, Y Wang, GH Guyatt, JS Mikita, J Roberts, ... Bmj 368, 2020 | 110 | 2020 |
| Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis RAC Siemieniuk, JJ Bartoszko, JPD Martinez, E Kum, A Qasim, ... bmj 374, 2021 | 100 | 2021 |
| Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline Z Ye, B Rochwerg, Y Wang, NK Adhikari, S Murthy, F Lamontagne, ... Cmaj 192 (20), E536-E545, 2020 | 87 | 2020 |
| Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: systematic review and network meta-analysis Y Wang, Z Ye, L Ge, RAC Siemieniuk, X Wang, Y Wang, L Hou, Z Ma, ... bmj 368, 2020 | 64 | 2020 |
| Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: an updated systematic review and network meta-analysis of randomized trials Y Wang, L Ge, Z Ye, RA Siemieniuk, A Reintam Blaser, X Wang, A Perner, ... Intensive Care Medicine 46 (11), 1987-2000, 2020 | 50 | 2020 |
| Comparing renal replacement therapy modalities in critically ill patients with acute kidney injury: a systematic review and network meta-analysis Z Ye, Y Wang, L Ge, GH Guyatt, D Collister, W Alhazzani, SM Bagshaw, ... Critical care explorations 3 (5), 2021 | 33 | 2021 |
| Heparin-induced thrombocytopenia: a critical appraisal of clinical practice guidelines with the AGREE II instrument Y Wang, ZK Ye, JF Li, XL Cui, LH Liu Thrombosis Research 166, 10-18, 2018 | 15 | 2018 |
| The Efficacy and Safety of Medical and Surgical Therapy in Patients With Primary Hyperparathyroidism: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials Z Ye, SJ Silverberg, A Sreekanta, K Tong, Y Wang, Y Chang, M Zhang, ... Journal of Bone and Mineral Research, 2022 | 12 | 2022 |
| A systematic survey identified methodological issues in studies estimating anchor-based minimal important differences in patient-reported outcomes Y Wang, T Devji, A Qasim, Q Hao, V Wong, M Bhatt, M Prasad, Y Wang, ... Journal of Clinical Epidemiology 142, 144-151, 2022 | 11 | 2022 |
| Instruments assessing risk of bias of randomized trials frequently included items that are not addressing risk of bias issues Y Wang, M Ghadimi, Q Wang, L Hou, D Zeraatkar, A Iqbal, C Ho, L Yao, ... Journal of Clinical Epidemiology, 2022 | 9 | 2022 |
| Antidepressant use and risk of venous thromboembolism: a systematic review and meta-analysis Y Wang, Z Ye, L Liu, X Cui Journal of Pharmacy & Pharmaceutical Sciences 22, 57-71, 2019 | 9 | 2019 |
| Drug treatments for COVID-19: living systematic review and network meta-analysis RA Siemieniuk, JJ Bartoszko, L Ge, D Zeraatkar, A Izcovich, E Kum, ... BMJ 373, n967, 2021 | | 2021 |
| Prophylaxis against covid-19: living systematic review and network meta-analysis A Darzi, M Ghadimi, F Lamontagne, M Loeb | | 2021 |
